(Q45011062)

English

Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes mellitus: a matching-adjusted indirect comparison of randomized trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes mellitus: a matching-adjusted indirect comparison of randomized trials (English)

1 reference

Europe PubMed Central

8 December 2017

type 2 diabetes

0 references

2

object named as

Eric Q Wu

1 reference

Europe PubMed Central

8 December 2017

author name string

James E Signorovitch

1

1 reference

Europe PubMed Central

8 December 2017

Elyse Swallow

3

1 reference

Europe PubMed Central

8 December 2017

Evan Kantor

4

1 reference

Europe PubMed Central

8 December 2017

Liangyi Fan

5

1 reference

Europe PubMed Central

8 December 2017

Jean-Bernard Gruenberger

6

1 reference

Europe PubMed Central

8 December 2017

publication date

1 January 2011

1 reference

Europe PubMed Central

8 December 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

8 December 2017

31

1 reference

Europe PubMed Central

8 December 2017

9

1 reference

Europe PubMed Central

8 December 2017

665-674

1 reference

Europe PubMed Central

8 December 2017

Diabetes in Japan: a review of disease burden and approaches to treatment

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Emerging epidemic of type 2 diabetes in youth

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Global healthcare expenditure on diabetes for 2010 and 2030.

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

DPP-4 inhibitors: what may be the clinical differentiators?

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

A meta-analysis of placebo-controlled clinical trials assessing the efficacy and safety of incretin-based medications in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Indirect comparisons of competing interventions

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Use of indirect and mixed treatment comparisons for technology assessment

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

The cost to health plans of poor glycemic control

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.2165%2F11592490-000000000-00000

21 January 2018

Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21819162

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

1 reference

https://pubmed.ncbi.nlm.nih.gov/21819162

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21819162

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11592490-000000000-00000

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45011062&oldid=2062306423"